Compounds > ivabradine
Page last updated: 2024-09-04

ivabradine and Tachycardia, Ventricular

ivabradine has been researched along with Tachycardia, Ventricular in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's4 (44.44)24.3611
2020's4 (44.44)2.80

Authors

AuthorsStudies
Fu, NK; Ying, S; Zhang, J; Zhang, P1
Çetin, T; Çınar, T; Çinier, G; Eren, S; Hayıroğlu, Mİ; Keskin, K; Pay, L; Tekkeşin, Aİ; Tezen, O; Yumurtaş, AÇ1
Aziz, Z; Beaser, AD; Kohli, U; Nayak, HM1
Mackiewicz, U; Mączewski, M; Marciszek, M; Oknińska, M; Paterek, A1
Klug, D; Vaksmann, G1
Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Kochhäuser, S; Lange, PS; Leitz, P; Weller, J1
Asrar Ul Haq, M; Mutha, V; Rudd, N; Subiakto, I; Van Gaal, WJ1
Adler, A; Meir, I; Rosso, R; Viskin, S1
Brink, PR; Bucchi, A; Cohen, IS; Danilo, P; Plotnikov, AN; Robinson, RB; Rosen, MR; Shlapakova, I1

Trials

1 trial(s) available for ivabradine and Tachycardia, Ventricular

ArticleYear
Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial infarc
    Trials, 2014, Sep-07, Volume: 15

    Topics: Anti-Arrhythmia Agents; Atorvastatin; Benzazepines; Biomarkers; Clinical Protocols; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Emergencies; Femoral Neck Fractures; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Middle Aged; Myocardial Infarction; Orthopedic Procedures; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Pyrroles; Research Design; Risk Factors; Severity of Illness Index; Tachycardia, Ventricular; Tomography, X-Ray Computed; Treatment Outcome; Victoria

2014

Other Studies

8 other study(ies) available for ivabradine and Tachycardia, Ventricular

ArticleYear
Ivabradine in the treatment of non-paroxysmal junctional tachycardia with interference atrioventricular dissociation: A case report.
    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2023, Volume: 28, Issue:4

    Topics: Electrocardiography; Heart Block; Heart Rate; Humans; Ivabradine; Tachycardia, Sinus; Tachycardia, Ventricular

2023
Effect of ivabradine on ventricular arrhythmias in heart failure patients with reduced ejection fraction.
    Revista da Associacao Medica Brasileira (1992), 2023, Volume: 69, Issue:12

    Topics: Arrhythmias, Cardiac; Heart Failure; Humans; Ivabradine; Retrospective Studies; Stroke Volume; Tachycardia, Ventricular; Ventricular Dysfunction, Left

2023
Ventricular arrhythmia suppression with ivabradine in a patient with catecholaminergic polymorphic ventricular tachycardia refractory to nadolol, flecainide, and sympathectomy.
    Pacing and clinical electrophysiology : PACE, 2020, Volume: 43, Issue:5

    Topics: Adolescent; Cardiovascular Agents; Electrocardiography; Exercise Test; Flecainide; Humans; Ivabradine; Male; Nadolol; Phenotype; Sympathectomy; Tachycardia, Ventricular

2020
Ivabradine is as effective as metoprolol in the prevention of ventricular arrhythmias in acute non-reperfused myocardial infarction in the rat.
    Scientific reports, 2020, 09-14, Volume: 10, Issue:1

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Calcium Signaling; Cells, Cultured; Heart Rate; Ivabradine; Male; Metoprolol; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Wistar; Ryanodine Receptor Calcium Release Channel; Tachycardia, Ventricular; Ventricular Fibrillation

2020
Efficacy of ivabradine to control ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
    Pacing and clinical electrophysiology : PACE, 2018, Volume: 41, Issue:10

    Topics: Adolescent; Anti-Arrhythmia Agents; Cardiovascular Agents; Electrocardiography; Exercise Test; Female; Flecainide; Humans; Ivabradine; Male; Nadolol; Tachycardia, Ventricular; Young Adult

2018
Ivabradine Aggravates the Proarrhythmic Risk in Experimental Models of Long QT Syndrome.
    Cardiovascular toxicology, 2019, Volume: 19, Issue:2

    Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Heart Conduction System; Heart Rate; Isolated Heart Preparation; Ivabradine; Long QT Syndrome; Potassium; Rabbits; Risk Assessment; Sotalol; Tachycardia, Ventricular; Time Factors; Veratridine

2019
Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2013, Volume: 15, Issue:3

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Benzazepines; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Equipment Design; Equipment Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Patient Selection; Prospective Studies; Tachycardia, Sinus; Tachycardia, Ventricular; Treatment Outcome

2013
HCN212-channel biological pacemakers manifesting ventricular tachyarrhythmias are responsive to treatment with I(f) blockade.
    Heart rhythm, 2008, Volume: 5, Issue:2

    Topics: Animals; Benzazepines; Calcium Channels; Cardiac Pacing, Artificial; Cardiovascular Agents; Catheter Ablation; Defibrillators, Implantable; Dogs; Electrophysiology; Ivabradine; Male; Muscle Cells; Rats; Risk Factors; Tachycardia, Ventricular

2008